The Advisory Council on Intellectual Property (ACIP) has released an options paper for arising from its Review of the (Registered) Designs System.
auDA, the body which administers the domain name system in the .au (i.e. Australia) space (OK, ccTLD) has embarked on a review (pdf) of its WhoIS policy. There are 2 main issues: Should there be any changes to auDA’s WHOIS Policy covering the collection, disclosure and use of WHOIS data for .au domain names? Should access to .au domain name data (other than via WHOIS) be opened up? Apparently, there was a workshop in October.. Read More
ACIP has published an issues paper reviewing the operation of the Designs Act 2003 for the first time since it came into force.
ACIP has released an options paper on what to do about the innovation patent system and raised 3 options for comment …
auda is conducting a review of the auDRP – the dispute resolution policy covering domain names registered in the .au domain name space. The auDRP was derived from the UDRP, so many of the principles worked out under the latter are equally applicable under the auDRP. Two of the main differences, however, are that under the auDRP: a complainant may have rights sufficient to found a complaint “in a name”, not just a trade.. Read More
Last month, the Parliamentary Secretary for Industry and Innovation, Mark Dreyfus, has appointed a panel to review the patenting of pharmaceuticals in Australia. Now the Panel have published a Background and Issues Paper. The Panel’s initial impressions of key issues include: a number of concerns have been raised about the length and breadth of protection provided by the extension of term provisions, that is, the duration of the extension and the types of pharmaceutical.. Read More
The Parliamentary Secretary for Industry and Innovation, Mark Dreyfus, has appointed a panel to review the patenting of pharmaceuticals in Australia. According to the Terms of Reference, the review: will evaluate whether the system for pharmaceutical patents is effectively balancing the objectives of securing timely access to competitively priced pharmaceuticals, fostering innovation and supporting employment in research and industry. Central to this will be an analysis of the pharmaceutical extension of term provisions of.. Read More
The ALRC has published an Issues Paper for its inquiry into Copyright and the Digital Economy. In an attempt to provide some structure to the anticipated submissions, the Issues Paper propounds some 55 questions over a range of topics including: should (maybe that should include “can”) Australia adopt a “fair use” exception (questions 52 – 53) – an earlier assessment by the CLRC (pdf – see p.7 for the recommendations); is there a.. Read More
Following my post on the ALRC’s reference re exceptions in the digital environment, a couple of people kindly pointed out the Attorney General’s department is also conducting a review of the exceptions to technological protection measures. A technological protection measure is … well, anyway, since the Sony v Stevens stuff up, the definition has been “fixed up” to close that gulf by adding access control technological protection measure as well. Section 116AN provides for.. Read More
The Government has announced the finalised terms of reference for the Australian Law Reform’s inquiry into copyright: I refer to the ALRC for inquiry and report pursuant to subsection 20(1) of the Australian Law Reform Commission Act 1996 the matter of whether the exceptions and statutory licences in the Copyright Act 1968, are adequate and appropriate in the digital environment. Amongst other things, the ALRC is to consider whether existing exceptions are appropriate.. Read More